Medtronic plc (MDT) FY2025 Q3 P&L / Income Statement

Medtronic plc (MDT) FY2025 Q3 P&L / Income Statement

Income statement for 2024-10-26 through 2025-01-24. View: Geography (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

8,292,000,000 US dollars

Cost of products sold, excluding amortization of intangible assets

2,779,000,000 US dollars

Gross profit (calculated)

5,513,000,000 US dollars

Operating costs, net of other operating income (calculated)

3,868,000,000 US dollars

Operating profit

1,646,000,000 US dollars

Other income (expense), net (calculated)

negative 106,000,000 US dollars

Income before income taxes

1,540,000,000 US dollars

Income tax provision

237,000,000 US dollars

Net income

1,303,000,000 US dollars

UNITED STATES

4,237,000,000 US dollars

International

4,055,000,000 US dollars

Research and development expense

675,000,000 US dollars

Selling, general, and administrative expense

2,717,000,000 US dollars

Amortization of intangible assets

416,000,000 US dollars

Restructuring charges, net

43,000,000 US dollars

Certain litigation charges, net

22,000,000 US dollars

Other operating (income) expense, net

negative 5,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Medtronic plc: $1.29 B; to noncontrolling interests: $9.00 M.

• The amounts that make up operating profit come to $1,645.00 M and operating profit is $1,646.00 M; the $1.00 M difference is within the rounding of the filed amounts.